Skip to main content
SpringerLink
Log in

Management of T4a Laryngeal Cancer

  • Head and Neck: Laryngeal Cancer (C Piazza, Section Editor)
  • Published:
Current Otorhinolaryngology Reports Aims and scope Submit manuscript

Abstract

Purpose of the Review

The aim of this study is to compare the results of surgical and non-surgical approach for T4a laryngeal cancer in term of curative effects, complications, and functional results by means of a systematic review of the most recent literature.

Recent Findings

Despite the recommendations contained in the guidelines, a general rise in non-surgical treatments and declining use of total laryngectomy has occurred during the last decades. This has paralleled some evidence of declining survival for advanced laryngeal cancer in many countries.

Summary

Recent data clearly demonstrate the superiority of total laryngectomy and post-operative radiotherapy, which produce a substantial long-term control and survival rates for patients with T4 laryngeal cancer. The most negative prognostic factor is represented by the N status. Open partial laryngectomy, in light of its good and encouraging oncological/functional results, could represent an alternative to total laryngectomy for selected patients affected by laryngeal cancer in certain T4a subcategories, i.e., those with limited anterior extension. Considering the worse oncologic results, principally in patients with poor general conditions and T4a cancer, non-surgical larynx preservation should only be addressed to carefully selected patients who refused total laryngectomy, characterized by more limited T4a disease, minimal involvement through the cartilage, and without pre-treatment impairment of laryngeal functions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Fu X, Zhou Q, Zhang X. Efficacy comparison between total laryngectomy and nonsurgical organ-preservation modalities in treatment of advanced stage laryngeal cancer: a meta-analysis. Medicine (Baltimore). 2016;95(14):e3142. doi:10.1097/MD.0000000000003142.

    Article  Google Scholar 

  2. • Tomeh C, Holsinger FC. Laryngeal cancer. Curr Opin Otolaryngol Head Neck Surg. 2014;22(2):147–53. doi:10.1097/MOO.0000000000000032. A concise review about the panorama of laryngeal cancer

    Article  PubMed  Google Scholar 

  3. Stankovic M, Milisavljevic D, Stojanov D, Zivic M, Zivaljevic S, Stankovic I, et al. Influential factors, complications and survival rate of primary and salvage total laryngectomy for advanced laryngeal cancer. Coll Antropol. 2012;36(Suppl 2):7–12.

    PubMed  Google Scholar 

  4. Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, et al. Head and neck cancers, version 2.2014. Clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2014;12(10):1454–87.

    Google Scholar 

  5. TNM Classification of Malignant Tumours. Seventh ed. ed. New York: Wiley-Liss; 2010.

  6. Gussenbauer C. Über die erste durch Th. Billroth am Menschen ausgeführte Kehlkopf - Exstirpation und die Anwendung eines künstlichen Kehlkopfes Arch Klin Chir. 1874;17(2):343–56.

    Google Scholar 

  7. Christiansen H, Wolff HA, Hess CF, Rodel RM, Steiner W, Matthias C. Larynx preservation clinical trial design: key issues and recommendations—a consensus panel summary: in regard to Lefebvre et al., for the larynx preservation consensus panel (Int J Radiat Oncol Biol Phys 2009;73:1293–1303). Int J Radiat Oncol Biol Phys. 2009;75(2):633; author reply −4. doi:10.1016/j.ijrobp.2009.05.062.

  8. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med. 1991;324(24):1685–90. doi:10.1056/NEJM199106133242402.

  9. Lefebvre JL, Rolland F, Tesselaar M, Bardet E, Leemans CR, Geoffrois L, et al. Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy. J Natl Cancer Inst. 2009;101(3):142–52. doi:10.1093/jnci/djn460.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Richard JM, Sancho-Garnier H, Pessey JJ, Luboinski B, Lefebvre JL, Dehesdin D, et al. Randomized trial of induction chemotherapy in larynx carcinoma. Oral Oncol. 1998;34(3):224–8.

    Article  CAS  PubMed  Google Scholar 

  11. Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349(22):2091–8. doi:10.1056/NEJMoa031317.

    Article  CAS  PubMed  Google Scholar 

  12. Pointreau Y, Garaud P, Chapet S, Sire C, Tuchais C, Tortochaux J, et al. Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation. J Natl Cancer Inst. 2009;101(7):498–506. doi:10.1093/jnci/djp007.

    Article  CAS  PubMed  Google Scholar 

  13. Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 1996;88(13):890–899.

  14. Posner MR, Hershock DM, Blajman CR, Mickiewicz E, Winquist E, Gorbounova V, et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med. 2007;357(17):1705–15. doi:10.1056/NEJMoa070956.

    Article  CAS  PubMed  Google Scholar 

  15. Lefebvre JL, Pointreau Y, Rolland F, Alfonsi M, Baudoux A, Sire C, et al. Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study. J Clin Oncol. 2013;31(7):853–9. doi:10.1200/JCO.2012.42.3988.

    Article  CAS  PubMed  Google Scholar 

  16. •• Denaro N, Russi EG, Lefebvre JL, Merlano MC. A systematic review of current and emerging approaches in the field of larynx preservation. Radiother Oncol. 2013; doi:10.1016/j.radonc.2013.08.016. A detailed review about the role of organ-sparing protocols in the treatment of laryngeal cancer

    PubMed  Google Scholar 

  17. Ang KK. Larynx preservation clinical trial design: summary of key recommendations of a consensus panel. Oncologist. 2010;15(Suppl 3):25–9. doi:10.1634/theoncologist.2010-S3-25.

    Article  PubMed  Google Scholar 

  18. Associazione Italiana di Oncologia Medica. Linee guida dei Tumori della Testa e del Collo. AIOM; 2015.

  19. American Society of Clinical O, Pfister DG, Laurie SA, Weinstein GS, Mendenhall WM, Adelstein DJ, et al. American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol. 2006;24(22):3693–704. doi:10.1200/JCO.2006.07.4559.

    Article  Google Scholar 

  20. Hoffman HT, Porter K, Karnell LH, Cooper JS, Weber RS, Langer CJ, et al. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope. 2006;116(9 Pt 2 Suppl 111):1–13. doi:10.1097/01.mlg.0000236095.97947.26.

    Article  PubMed  Google Scholar 

  21. •• Rosenthal DI, Mohamed AS, Weber RS, Garden AS, Sevak PR, Kies MS, et al. Long-term outcomes after surgical or nonsurgical initial therapy for patients with T4 squamous cell carcinoma of the larynx: a 3-decade survey. Cancer. 2015;121(10):1608–19. doi:10.1002/cncr.29241. An interesting analysis of oncological outcomes in T4 laryngeal cancer

    Article  PubMed  PubMed Central  Google Scholar 

  22. Bussu F, Paludetti G, Almadori G, De Virgilio A, Galli J, Micciche F, et al. Comparison of total laryngectomy with surgical (cricohyoidopexy) and nonsurgical organ-preservation modalities in advanced laryngeal squamous cell carcinomas: a multicenter retrospective analysis. Head Neck. 2013;35(4):554–61. doi:10.1002/hed.22994.

    Article  PubMed  Google Scholar 

  23. Francis E, Matar N, Khoueir N, Nassif C, Farah C, Haddad A. T4a laryngeal cancer survival: retrospective institutional analysis and systematic review. Laryngoscope. 2014;124(7):1618–23. doi:10.1002/lary.24557.

    Article  PubMed  Google Scholar 

  24. Dziegielewski PT, O'Connell DA, Klein M, Fung C, Singh P, Mlynarek AM, et al. Primary total laryngectomy versus organ preservation for T3/T4a laryngeal cancer: a population-based analysis of survival. J Otolaryngol Head Neck Surg. 2012;41(Suppl 1):S56–64.

    PubMed  Google Scholar 

  25. Grover S, Swisher-McClure S, Mitra N, Li J, Cohen RB, Ahn PH, et al. Total laryngectomy versus larynx preservation for T4a larynx cancer: patterns of care and survival outcomes. Int J Radiat Oncol Biol Phys. 2015;92(3):594–601. doi:10.1016/j.ijrobp.2015.03.004.

    Article  PubMed  Google Scholar 

  26. Timmermans AJ, de Gooijer CJ, Hamming-Vrieze O, Hilgers FJ, van den Brekel MW. T3-T4 laryngeal cancer in The Netherlands Cancer Institute; 10-year results of the consistent application of an organ-preserving/-sacrificing protocol. Head Neck. 2015;37(10):1495–503. doi:10.1002/hed.23789.

    Article  PubMed  Google Scholar 

  27. • Timmermans AJ, van Dijk BA, Overbeek LI, van Velthuysen ML, van Tinteren H, Hilgers FJ, et al. Trends in treatment and survival for advanced laryngeal cancer: a 20-year population-based study in The Netherlands. Head Neck. 2016;38(Suppl 1):E1247–55. doi:10.1002/hed.24200. An excursus on trends and survival rates in advanced laryngeal cancer in The Netherlands

    Article  PubMed  Google Scholar 

  28. •• Timme DW, Jonnalagadda S, Patel R, Rao K, Robbins KT. Treatment selection for T3/T4a laryngeal cancer: chemoradiation versus primary surgery. Ann Otol Rhinol Laryngol. 2015;124(11):845–51. doi:10.1177/0003489415588130. Addresses the science behind the treatment options for T3 and T4a laryngeal cancer

    Article  PubMed  Google Scholar 

  29. Luo XN, Chen LS, Zhang SY, Lu ZM, Huang Y. Effectiveness of chemotherapy and radiotherapy for laryngeal preservation in advanced laryngeal cancer: a meta-analysis and systematic review. Radiol Med. 2015;120(12):1153–69. doi:10.1007/s11547-015-0547-8.

    Article  PubMed  Google Scholar 

  30. Rodrigo JP, Lopez F, Llorente JL, Alvarez-Marcos C, Suarez C. Results of total laryngectomy as treatment for locally advanced laryngeal cancer in the organ-preservation era. Acta Otorrinolaringol Esp. 2015;66(3):132–8. doi:10.1016/j.otorri.2014.06.001.

    Article  PubMed  Google Scholar 

  31. • Gorphe P, Matias M, Moya-Plana A, Tabarino F, Blanchard P, Tao Y, et al. Results and survival of locally advanced AJCC 7th edition T4a laryngeal squamous cell carcinoma treated with primary total laryngectomy and postoperative radiotherapy. Ann Surg Oncol. 2016;23(8):2596–601. doi:10.1245/s10434-016-5217-0. An influential cohort study about treatment of T4 laryngeal cancer

    Article  PubMed  Google Scholar 

  32. Sanabria A, Chaves AL, Kowalski LP, Wolf GT, Saba NF, Forastiere AA, et al. Organ preservation with chemoradiation in advanced laryngeal cancer: the problem of generalizing results from randomized controlled trials. Auris Nasus Larynx. 2016; doi:10.1016/j.anl.2016.06.005.

    PubMed  Google Scholar 

  33. Al-Gilani M, Skillington SA, Kallogjeri D, Haughey B, Piccirillo JF. Surgical vs nonsurgical treatment modalities for T3 glottic squamous cell carcinoma. JAMA Otolaryngol Head Neck Surg. 2016; doi:10.1001/jamaoto.2016.1609.

    Google Scholar 

  34. Succo G, Crosetti E, Bertolin A, Lucioni M, Arrigoni G, Panetta V, et al. Benefits and drawbacks of open partial horizontal laryngectomies, Part B: intermediate and selected advanced stage laryngeal carcinoma. Head Neck. 2016;38(Suppl 1):E649–57. doi:10.1002/hed.24064.

    Article  PubMed  Google Scholar 

  35. Reizenstein JA, Holmberg L, Bergqvist M, Linder A, Ekman S, Loden B, et al. Time trends in T3 to T4 laryngeal cancer: a population-based long-term analysis. Head Neck. 2014;36(12):1727–31. doi:10.1002/hed.23524.

    Article  PubMed  Google Scholar 

  36. Sherman EJ, Fisher SG, Kraus DH, Zelefsky MJ, Seshan VE, Singh B, et al. TALK score: development and validation of a prognostic model for predicting larynx preservation outcome. Laryngoscope. 2012;122(5):1043–50. doi:10.1002/lary.23220.

    Article  PubMed  Google Scholar 

  37. Forastiere AA, Zhang Q, Weber RS, Maor MH, Goepfert H, Pajak TF, et al. Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol. 2013;31(7):845–52. doi:10.1200/JCO.2012.43.6097.

    Article  CAS  PubMed  Google Scholar 

  38. Lefebvre JL. Larynx preservation. Curr Opin Oncol. 2012;24(3):218–22. doi:10.1097/CCO.0b013e3283523c95.

    Article  PubMed  Google Scholar 

  39. Dabholkar JP, Kapre NM, Gupta HK. Results of voice rehabilitation with Provox prosthesis and factors affecting the voice quality. J Voice. 2015;29(6):777 e1-8. doi:10.1016/j.jvoice.2015.01.003.

    Article  PubMed  Google Scholar 

  40. Silver CE, Beitler JJ, Shaha AR, Rinaldo A, Ferlito A. Current trends in initial management of laryngeal cancer: the declining use of open surgery. Eur Arch Otorhinolaryngol. 2009;266(9):1333–52. doi:10.1007/s00405-009-1028-2.

    Article  PubMed  Google Scholar 

  41. Elmiyeh B, Dwivedi RC, Jallali N, Chisholm EJ, Kazi R, Clarke PM, et al. Surgical voice restoration after total laryngectomy: an overview. Indian J Cancer. 2010;47(3):239–47. doi:10.4103/0019-509X.64707.

    Article  CAS  PubMed  Google Scholar 

  42. Serafini I. Reconstructive laryngectomy. Rev Laryngol Otol Rhinol (Bord). 1972;93(1):23–38.

    CAS  Google Scholar 

  43. Laccourreye O, Brasnu D, Jouffre V, Couloigner V, Naudo P, Laccourreye H. Supra-cricoid partial laryngectomy extended to the anterior arch of the cricoid with tracheo-crico-hyoido-epiglottopexy. Oncologic and functional results. Ann Otolaryngol Chir Cervicofac. 1996;113(1):15–9.

    CAS  PubMed  Google Scholar 

  44. Majer EH, Rieder W. Technic of laryngectomy permitting the conservation of respiratory permeability (cricohyoidopexy). Ann Otolaryngol. 1959;76:677–81.

    CAS  PubMed  Google Scholar 

  45. Piquet JJ, Desaulty A, Decroix G. Crico-hyoido-epiglotto-pexy. Surgical technic and functional results. Ann Otolaryngol Chir Cervicofac. 1974;91(12):681–6.

    CAS  PubMed  Google Scholar 

  46. Labayle J, Bismuth R. Total laryngectomy with reconstitution. Ann Otolaryngol Chir Cervicofac. 1971;88(4):219–28.

    CAS  PubMed  Google Scholar 

  47. Tibbetts KM, Tan M. Role of advanced laryngeal imaging in glottic cancer: early detection and evaluation of glottic neoplasms. Otolaryngol Clin N Am. 2015;48(4):565–84. doi:10.1016/j.otc.2015.04.004.

    Article  Google Scholar 

  48. Lee HS, Chun BG, Kim SW, Kim ST, Oh JH, Hong JC, et al. Transoral laser microsurgery for early glottic cancer as one-stage single-modality therapy. Laryngoscope. 2013;123(11):2670–4. doi:10.1002/lary.24080.

    Article  PubMed  Google Scholar 

  49. Abouyared M, Ojo R, Fundakowski C, Lo K, Sargi Z. Transoral laser microsurgery in previously irradiated patients with laryngeal cancer. Am J Otolaryngol. 2014;35(3):279–85. doi:10.1016/j.amjoto.2014.03.004.

    Article  PubMed  Google Scholar 

  50. •• Peretti G, Piazza C, Mora F, Garofolo S, Guastini L. Reasonable limits for transoral laser microsurgery in laryngeal cancer. Curr Opin Otolaryngol Head Neck Surg. 2016;24(2):135–9. doi:10.1097/MOO.0000000000000240. Strong indications and limits of transoral laser microsurgery in the treatment of laryngeal cancer

    Article  PubMed  Google Scholar 

  51. Forastiere AA, Weber RS, Trotti A. Organ preservation for advanced larynx cancer: issues and outcomes. J Clin Oncol. 2015;33(29):3262–8. doi:10.1200/JCO.2015.61.2978.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Bocca E, Pignataro O, Oldini C. Supraglottic laryngectomy: 30 years of experience. Ann Otol Rhinol Laryngol. 1983;92(1 Pt 1):14–8.

    Article  CAS  PubMed  Google Scholar 

  53. Chevalier D, Laccourreye O, Brasnu D, Laccourreye H, Piquet JJ. Cricohyoidoepiglottopexy for glottic carcinoma with fixation or impaired motion of the true vocal cord: 5-year oncologic results with 112 patients. Ann Otol Rhinol Laryngol. 1997;106(5):364–9.

    Article  CAS  PubMed  Google Scholar 

  54. Laccourreye O, Brasnu D, Biacabe B, Hans S, Seckin S, Weinstein G. Neo-adjuvant chemotherapy and supracricoid partial laryngectomy with cricohyoidopexy for advanced endolaryngeal carcinoma classified as T3-T4: 5-year oncologic results. Head Neck. 1998;20(7):595–9.

    Article  CAS  PubMed  Google Scholar 

  55. de Vincentiis M, Minni A, Gallo A, Di Nardo A. Supracricoid partial laryngectomies: oncologic and functional results. Head Neck. 1998;20(6):504–9.

    Article  PubMed  Google Scholar 

  56. Bron L, Brossard E, Monnier P, Pasche P. Supracricoid partial laryngectomy with cricohyoidoepiglottopexy and cricohyoidopexy for glottic and supraglottic carcinomas. Laryngoscope. 2000;110(4):627–34. doi:10.1097/00005537-200004000-00017.

    Article  CAS  PubMed  Google Scholar 

  57. Gallo A, Manciocco V, Simonelli M, Pagliuca G, D'Arcangelo E, de Vincentiis M. Supracricoid partial laryngectomy in the treatment of laryngeal cancer: univariate and multivariate analysis of prognostic factors. Arch Otolaryngol Head Neck Surg. 2005;131(7):620–5. doi:10.1001/archotol.131.7.620.

    Article  PubMed  Google Scholar 

  58. Lima RA, Freitas EQ, Dias FL, Barbosa MM, Kligerman J, Soares JR, et al. Supracricoid laryngectomy with cricohyoidoepiglottopexy for advanced glottic cancer. Head Neck. 2006;28(6):481–6. doi:10.1002/hed.20361.

    Article  PubMed  Google Scholar 

  59. Laudadio P, Presutti L, Dall'olio D, Cunsolo E, Consalici R, Amorosa L, et al. Supracricoid laryngectomies: long-term oncological and functional results. Acta Otolaryngol. 2006;126(6):640–9. doi:10.1080/00016480500469024.

    Article  PubMed  Google Scholar 

  60. Rizzotto G, Crosetti E, Lucioni M, Bertolin A, Monticone V, Sprio AE, et al. Oncological outcomes of supratracheal laryngectomy: a critical analysis. Head Neck. 2015;37(10):1417–24. doi:10.1002/hed.23773.

    Article  PubMed  Google Scholar 

  61. Paleri V, Drinnan M, van den Brekel MW, Hinni ML, Bradley PJ, Wolf GT, et al. Vascularized tissue to reduce fistula following salvage total laryngectomy: a systematic review. Laryngoscope. 2014;124(8):1848–53. doi:10.1002/lary.24619.

    Article  PubMed  Google Scholar 

  62. Agra IM, Ferlito A, Takes RP, Silver CE, Olsen KD, Stoeckli SJ, et al. Diagnosis and treatment of recurrent laryngeal cancer following initial nonsurgical therapy. Head Neck. 2012;34(5):727–35. doi:10.1002/hed.21739.

    Article  PubMed  Google Scholar 

  63. Paleri V, Thomas L, Basavaiah N, Drinnan M, Mehanna H, Jones T. Oncologic outcomes of open conservation laryngectomy for radiorecurrent laryngeal carcinoma: a systematic review and meta-analysis of English-language literature. Cancer. 2011;117(12):2668–76. doi:10.1002/cncr.25831.

    Article  PubMed  Google Scholar 

  64. van der Putten L, de Bree R, Kuik DJ, Rietveld DH, Buter J, Eerenstein SE, et al. Salvage laryngectomy: oncological and functional outcome. Oral Oncol. 2011;47(4):296–301. doi:10.1016/j.oraloncology.2011.02.002.

    Article  PubMed  Google Scholar 

  65. Klozar J, Cada Z, Koslabova E. Complications of total laryngectomy in the era of chemoradiation. Eur Arch Otorhinolaryngol. 2012;269(1):289–93. doi:10.1007/s00405-011-1598-7.

    Article  PubMed  Google Scholar 

  66. Erdag MA, Arslanoglu S, Onal K, Songu M, Tuylu AO. Pharyngocutaneous fistula following total laryngectomy: multivariate analysis of risk factors. Eur Arch Otorhinolaryngol. 2013;270(1):173–9. doi:10.1007/s00405-012-2111-7.

    Article  PubMed  Google Scholar 

  67. Sewnaik A, Keereweer S, Al-Mamgani A, Baatenburg de Jong RJ, Wieringa MH, Meeuwis CA, et al. High complication risk of salvage surgery after chemoradiation failures. Acta Otolaryngol. 2012;132(1):96–100. doi:10.3109/00016489.2011.617779.

    Article  PubMed  Google Scholar 

  68. Patel UA, Moore BA, Wax M, Rosenthal E, Sweeny L, Militsakh ON, et al. Impact of pharyngeal closure technique on fistula after salvage laryngectomy. JAMA Otolaryngol Head Neck Surg. 2013;139(11):1156–62. doi:10.1001/jamaoto.2013.2761.

    Article  PubMed  Google Scholar 

  69. de Vincentiis M, De Virgilio A, Bussu F, Gallus R, Gallo A, Bastanza G, et al. Oncologic results of the surgical salvage of recurrent laryngeal squamous cell carcinoma in a multicentric retrospective series: emerging role of supracricoid partial laryngectomy. Head Neck. 2015;37(1):84–91. doi:10.1002/hed.23563.

    Article  PubMed  Google Scholar 

  70. Santoro R, Meccariello G, Mannelli G, Bini B, Paiar F, Gallo O. Surgical options in radiotherapy-failed early glottic cancer. Eur Arch Otorhinolaryngol. 2014;271(4):777–85. doi:10.1007/s00405-013-2583-0.

    Article  PubMed  Google Scholar 

  71. Li M, Lorenz RR, Khan MJ, Burkey BB, Adelstein DJ, Greskovich Jr JF, et al. Salvage laryngectomy in patients with recurrent laryngeal cancer in the setting of nonoperative treatment failure. Otolaryngol Head Neck Surg. 2013;149(2):245–51. doi:10.1177/0194599813486257.

    Article  PubMed  Google Scholar 

  72. Basheeth N, O'Leary G, Sheahan P. Elective neck dissection for no neck during salvage total laryngectomy: findings, complications, and oncological outcome. JAMA Otolaryngol Head Neck Surg. 2013;139(8):790–6. doi:10.1001/jamaoto.2013.3995.

    Article  PubMed  Google Scholar 

  73. Sayles M, Grant DG. Preventing pharyngo-cutaneous fistula in total laryngectomy: a systematic review and meta-analysis. Laryngoscope. 2014;124(5):1150–63. doi:10.1002/lary.24448.

    Article  PubMed  Google Scholar 

  74. Timmermans AJ, Lansaat L, Theunissen EA, Hamming-Vrieze O, Hilgers FJ, van den Brekel MW. Predictive factors for pharyngocutaneous fistulization after total laryngectomy. Ann Otol Rhinol Laryngol. 2014;123(3):153–61. doi:10.1177/0003489414522972.

    Article  PubMed  Google Scholar 

  75. Powell J, Ullal UR, Ahmed O, Ragbir M, Paleri V. Tissue transfer to post-chemoradiation salvage laryngectomy defects to prevent pharyngocutaneous fistula: single-centre experience. J Laryngol Otol. 2014:1–3. doi:10.1017/S0022215114000504.

  76. Suslu N, Senirli RT, Gunaydin RO, Ozer S, Karakaya J, Hosal AS. Pharyngocutaneous fistula after salvage laryngectomy. Acta Otolaryngol. 2015;135(6):615–21. doi:10.3109/00016489.2015.1009639.

    Article  PubMed  Google Scholar 

  77. Busoni M, Deganello A, Gallo O. Pharyngocutaneous fistula following total laryngectomy: analysis of risk factors, prognosis and treatment modalities. Acta Otorhinolaryngol Ital. 2015;35(6):400–5. doi:10.14639/0392-100X-626.

    CAS  PubMed  PubMed Central  Google Scholar 

  78. Putten L, Bree R, Doornaert PA, Buter J, Eerenstein SE, Rietveld DH, et al. Salvage surgery in post-chemoradiation laryngeal and hypopharyngeal carcinoma: outcome and review. Acta Otorhinolaryngol Ital. 2015;35(3):162–72.

    CAS  PubMed  PubMed Central  Google Scholar 

  79. Wulff NB, Andersen E, Kristensen CA, Sorensen CH, Charabi B, Homoe P. Prognostic factors for survival after salvage total laryngectomy following radiotherapy or chemoradiation failure: a 10-year retrospective longitudinal study in eastern Denmark. Clin Otolaryngol. 2016; doi:10.1111/coa.12726.

    PubMed  Google Scholar 

  80. Patel UA, Keni SP. Pectoralis myofascial flap during salvage laryngectomy prevents pharyngocutaneous fistula. Otolaryngol Head Neck Surg. 2009;141(2):190–5. doi:10.1016/j.otohns.2009.03.024.

    Article  PubMed  Google Scholar 

  81. Anschutz L, Nisa L, Elicin O, Bojaxhiu B, Caversaccio M, Giger R. Pectoralis major myofascial interposition flap prevents postoperative pharyngocutaneous fistula in salvage total laryngectomy. Eur Arch Otorhinolaryngol 2016;273(11):3943–3949. doi:10.1007/s00405-016-4049-7.

  82. Ridha H, Clarke PM, Wood SH. Re: “Long-term oral intake through a salivary bypass tube with chronic pharyngocutaneous fistula”. Am J Otolaryngol. 2013;34(5):615–6. doi:10.1016/j.amjoto.2013.03.009.

    Article  PubMed  Google Scholar 

  83. Lopez F, Obeso S, Camporro D, Fueyo A, Suarez C, Llorente JL. Outcomes following pharyngolaryngectomy with fasciocutaneous free flap reconstruction and salivary bypass tube. Laryngoscope. 2013;123(3):591–6. doi:10.1002/lary.23695.

    Article  PubMed  Google Scholar 

  84. Crosetti E, Fantini M, Arrigoni G, Salonia L, Lombardo A, Atzori A, et al. Telephonic voice intelligibility after laryngeal cancer treatment: is therapeutic approach significant? Eur Arch Otorhinolaryngol. 2016; doi:10.1007/s00405-016-4217-9.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Head and Neck Oncology Service, Oncology Department, University of Turin, Candiolo Cancer Institute, Candiolo, Italy

    Erika Crosetti, Alessandra Caracciolo, Giulia Arrigoni, Marco Fantini & Giovanni Succo

  2. Department of Clinical and Biological Sciences, University of Turin, Turin, Italy

    Andrea E. Sprio & Giovanni N. Berta

Authors
  1. Erika Crosetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alessandra Caracciolo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Giulia Arrigoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marco Fantini
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Andrea E. Sprio
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Giovanni N. Berta
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Giovanni Succo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Erika Crosetti.

Ethics declarations

Conflict of Interest

Dr. Erika Crosetti, Dr. Alessandra Caracciolo, Dr. Giulia Arrigoni, Dr. Marco Fantini, Dr. Andrea E. Sprio, Dr. Giovanni N. Berta, and Dr. Giovanni Succo declare that they have no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Head and Neck: Laryngeal Cancer

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Crosetti, E., Caracciolo, A., Arrigoni, G. et al. Management of T4a Laryngeal Cancer. Curr Otorhinolaryngol Rep 5, 69–82 (2017). https://doi.org/10.1007/s40136-017-0142-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40136-017-0142-8

Keywords

Search

Navigation